Back to top

["Type": "Adverse Reaction To Thrombolytics"]

Performance/Reporting Period
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for adverse reactions to thrombolytic medications used for treatment of ST-segment elevation myocardial infaction (STEMI).
Data Element Scope: This value set may use a model element related to Disorder.
Inclusion Criteria: Includes SNOMED-CT codes that represent adverse reactions to thrombolytic medications for STEMI treatment.
Exclusion Criteria: No exclusions.

Constrained to codes in the Type: Adverse Reaction To Thrombolytics value set (2.16.840.1.113762.1.4.1170.6)

QDM Attribute and Definition


The characterization of the reaction (e.g., hypersensitivity, rash, gastroenteric symptoms, etc.).
Last Updated: Jul 15, 2022